Brief: Hemostemix signs agreement with CRO service provider Topstone Research
26/09/2017 13:18
Sept 26 (Reuters) - Hemostemix Inc HEM.V :
* Hemostemix-Has engaged Topstone Research to provide
services to advance co's international, multicenter, phase ii
clinical trial for patients with CLI
Source text for Eikon: ID:nGNXOEMGWa
Further company coverage: HEM.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update